v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues $ 4,725 $ 3,453 $ 9,956 $ 6,407
Cost of Revenues 1,396 896 2,782 1,780
Gross Profit 3,329 2,557 7,174 4,627
Operating Expenses        
Research and development 4,912 3,223 8,997 5,931
Sales and marketing 2,324 2,073 4,600 3,712
General and administrative 6,897 8,828 13,002 17,999
Acquisition-related costs 147 535 268 1,005
Impairment of goodwill 7,570 0 7,570 0
Amortization of intangibles 1,369 1,191 2,691 1,693
Total Operating Expenses 23,219 15,850 37,128 30,340
Loss from Operations (19,890) (13,293) (29,954) (25,713)
Other Income (Expense)        
Interest income (expense), net 176 1,555 178 1,206
Loss on exchange of debt for equity 0 0 0 (30)
Recovery of valuation allowance on related party loan - held for sale 0 7,462 0 7,345
Other (expense)/income, net (879) 125 (771) 511
Gain on related party loan - held for sale 0 49,817 0 49,817
Unrealized gain/(loss) on equity securities 247 (28,965) (1,256) (28,965)
Total Other Income (Expense) (456) 29,994 (1,849) 29,884
Net (Loss) Income, before tax (20,346) 16,701 (31,803) 4,171
Income tax benefit/(provision) 16 (2,195) (84) (2,204)
Net (Loss) Income (20,330) 14,506 (31,887) 1,967
Net (Loss) Income Attributable to Non-controlling Interest (458) (253) (804) (235)
Net Loss Attributable to Stockholders of Inpixon (19,872) 14,759 (31,083) 2,202
Net (Loss) Income Attributable to Common Stockholders (24,857) 14,759 (42,219) 2,202
Net (Loss) Income Attributable to Common Stockholders $ (24,857) $ 14,759 $ (42,219) $ 2,202
Net Income (Loss) Per Share        
Net (Loss) Income Per Share - Basic (in usd per share) $ (0.16) $ 0.13 $ (0.29) $ 0.02
Net (Loss) Income Per Share - Diluted (in usd per share) $ (0.16) $ 0.13 $ (0.29) $ 0.02
Weighted Average Shares Outstanding        
Basic (in shares) 153,519,283 110,040,532 146,052,371 94,577,520
Diluted (in shares) 153,519,283 110,041,378 146,052,371 94,591,619
Series 7 Convertible Preferred Stock        
Other Income (Expense)        
Accretion of preferred stock $ 0 $ 0 $ (4,555) $ 0
Series 8 Convertible Preferred Stock        
Other Income (Expense)        
Accretion of preferred stock (6,237) 0 (6,785) 0
Deemed dividend for the modification related to Series 8 Preferred Stock 0 0 (2,627) 0
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock 0 0 1,469 0
Amortization premium- modification related to Series 8 Preferred Stock $ 1,252 $ 0 $ 1,362 $ 0

Source